Skip to main content
. 2021 May 3;13:3619–3627. doi: 10.2147/CMAR.S307368

Table 4.

ORR, PFS and OS According to Median ANC

ANC N for CR+PR Percentage (%) P value
< 4.58 9 26.5
≥ 4.58 3 8.1 0.057
ANC mPFS 95% CI P value
< 4.58 7 4.4–9.6
≥ 4.58 5 4.4–5.7 0.024*
ANC mOS 95% CI P value
< 4.58 17.6 12.3–22.9
≥ 4.58 7.3 4.7–10.0 < 0.001*

Notes: The response to anlotinib between different groups were compared by Pearson χ2. The Log rank test was used for univariate analyses of PFS and OS. * p<0.05.